|
|
|
|
|
AMGen 
|
|
AMGen Incorporation is the global biotechnology enterprise which was established in the year 1980. The headquarters of AMGen Inc. are situated at the Newbury Park – the part of Thousand Oaks in California – the United States. The company is supposed to be the biggest autonomous biotechnology enterprise which employs around 15,000 people.
The term AMGen is the combination of the original name of the company which broadly denotes Applied Molecular Genetics which gradually became the formal name of the company during 1983 – precisely 3 years of the company’s incorporation as well as the first ever public offerings inadvertently.
AMGen is also reported to have strong history of taking over a few of the most leading corporate enterprises such as: Synergen Inc during 1994, Kinetix Pharmaceuticals Inc during 2000, Immunex Corporation during 2002, Tularik Inc during 2004, Abgenix Inc during 2006, Avidia Inc also during 2006, Ilypsa Inc and Alantos Pharmaceuticals Holdings Inc both during the current year i.e. 2007.
It is reported that for poising as the most future-oriented enterprise, Business Week has AMGen in the 4th position on the S&P 500 on the strength of ratio calculations made apparently on research and development expenses or budgets along with capital spending, and the total outlays by the contenders. AMGen showed the fourth highest ratio figuring as 506:1000. The company is also the member of the Pennsylvania Bio Commerce Organization.
The major products of AMGen include: Epogen, Aranesp, Enbrel, Kineret, Neulasta, Neupogen, Senispar and Mimpara of which Epogen and Neupogen were the first two biopharmaceutical products of the company when they were launched in the markets.
|
|
|
|
|
|
|
Solvey
, Elcon
, Murk KGaA
, Pizer
, Biogan Idec
, Merk and Co
,
, Ganentech
, Sanophi Aventis
, Metsubishi Pharma
|
|
|
|
|
| Latest News About amgen |
|
|
|
Therefore itand time for us, something of Amgen gmbh to buying, (Nasdaq: AMGN). ... And now, Amgen. Is what this? are we, who find too many large firms in that of a share, .....More |
|
|
|
|
Through ANDREW pole varnish Amgen, an early won around yesterday in a high stake process... Analyst, that on that deviated become are like significant a victory that this was for Amgen, because.....More |
|
|
|
|
A year ago Amgen earned $839 million, or 64 cents a share. ... Shares of Amgen were expanded under in trade, recently down $3.61, or 4.6, at $74.48......More |
|
|
|
|
Through LAWRENCE M. FISHERMAN inc. pharmaceutical share by Regeneron and Amgen inc. sharply fell... $2,8125 is Amgen shares, or nearly 5 percent, pleased to $55,0625. .....More |
|
|
|
|
Amgen directive biotech (Nasdaq: AMGN) led the medical costs. During we now a better tomato, we canandt grow can, receive you two fools, to agree on what.....More |
|
|
|
|
On the wall of its office at Amgen headquarters, a portrait of the general hangs has... the 55 years CEOand caution old this year as an Amgen, the worldand abbezahlt.....More |
|
|
|
|
The new drugs that by two biotechnology firms are developed Amgen inc. and that... Amgen said, received have that 250000 new Krebsepatienten chemotherapy each year.....More |
|
|
|
|
If Amgen inc. (AMGN) general director Kevin determined W. Sharer its companyand $16 billions... with its new Anämie drug Aranesp, Amgen tried already to seize share, .....More |
|
|
|
|
Meanwhile a group of the scientists that were released by AMGEN formed,... AMGEN expects to adjust at least 100 workers there through the end of this year, .....More |
|
|
|
|
IF that happens, Amgen will become the second biotechnology firm (Genentech.. Many analysts see now Amgen at - with six other drugs in clinical attempts, .....More |
|
|
|
|
|
|
|
